e-learning
resources
Vienna 2012
Monday, 03.09.2012
Endo meets obstruction: the new endoscopic treatment options for obstructive lung diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The critical statement of the asthma expert
N. Thomson (Glasgow, United Kingdom)
Source:
Annual Congress 2012 - Endo meets obstruction: the new endoscopic treatment options for obstructive lung diseases
Session:
Endo meets obstruction: the new endoscopic treatment options for obstructive lung diseases
Session type:
Symposium
Number:
1817
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
N. Thomson (Glasgow, United Kingdom). The critical statement of the asthma expert. Annual Congress 2012 - Endo meets obstruction: the new endoscopic treatment options for obstructive lung diseases
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
ERS/EAACI statement on adherence to international adult asthma guidelines
Source: Guideline 2021
Year: 2021
ERS/EAACI statement on adherence to international adult asthma guidelines
Source: Eur Respir Rev, 30 (161) 210132; 10.1183/16000617.0132-2021
Year: 2021
ERS/EAACI statement on adherence to international adult asthma guidelines
Source: Virtual Congress 2021 – ERS/EAACI statement on adherence to international adult asthma guidelines
Year: 2021
ERS/EAACI statement on severe exacerbations in asthma in adults: facts, priorities and key research questions
Source: Guideline 2019
Year: 2019
Manuscript cited in “Specific inhalation challenge in the diagnosis of occupational asthma: consensus statement”
Source: Eur Respir J 2014; 44: 1100
Year: 2014
Manuscript cited in “Specific inhalation challenge in the diagnosis of occupational asthma: consensus statement”
Source: Eur Respir J 2014; 44: 1099-1100
Year: 2014
Specific inhalation challenge in the diagnosis of occupational asthma: consensus statement
Source: Eur Respir J 2014; 43: 1573-1587
Year: 2014
Defining high probability of an asthma diagnosis in primary care: results from an expert consensus workshop
Source: Virtual Congress 2020 – Diagnosis and management of airways disease in primary care
Year: 2020
Cough clinical practice guidelines: A critical review of scientific evidence and recommendations
Source: International Congress 2016 – Epidemiological and clinical data regarding the modern management of chronic lung diseases
Year: 2016
Consultation on basic asthma research strategy
Source: Eur Respir J 2002; 20: 795-796
Year: 2002
Implementation of personalized treatment of asthma by improved phenotyping: Critical review of knowledge gaps and unmet research needs by the European asthma research & innovation partnership (EARIP) expert panel
Source: International Congress 2016 – Phenotyping asthma
Year: 2016
Belgium paediatric consensus workgroup statement on wheezing below age of 5
Source: Eur Respir J 2006; 28: Suppl. 50, 256s
Year: 2006
Occupational asthma: expert clinician rating of case histories
Source: Eur Respir J 2003; 22: Suppl. 45, 3s
Year: 2003
What is the difference between an evidence-based guideline and a consensus statement?
Source: Annual Congress 2006 - PG16 - The use of evidence-based medicine and practice for the clinician (jointly organised with the ACCP)
Year: 2006
How do the new guidelines work? Practical approach to the new guidelines for asthma diagnosis in children, discussion and Q&A
Source: Virtual Congress 2021 – The ERS guidelines for the diagnosis of asthma in children aged 5-16 years
Year: 2021
Research priorities in chronic breathlessness: international expert consensus
Source: International Congress 2019 – Hot topics in assessment and care for chronic lung diseases
Year: 2019
Increasing implementation and delivery of pulmonary rehabilitation: key messages from the new ATS/ERS policy statement
Source: Eur Respir J 2016; 47:1336-1341
Year: 2016
It is time for the world to take COPD seriously: a statement from the GOLD board of directors
Source: Eur Respir J, 54 (1) 1900914; 10.1183/13993003.00914-2019
Year: 2019
An ATS/ERS report: 100 key questions and needs in occupational asthma
Source: Eur Respir J 2006; 27: 607-614
Year: 2006
How did implementation of GINA guidelines change doctors therapeutical attitude in bronchial asthma
Source: Eur Respir J 2001; 18: Suppl. 33, 45s
Year: 2001
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept